* Streamline Health Solutions Inc STRM.OQ STRM.O is expected
to show a rise in quarterly revenue when it reports results on
September 8.
* The Alpharetta, Georgia-based company is expected to report
a 9.3% increase in revenue to $3.155 million from $2.89 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Streamline Health
Solutions Inc is for a loss of 5 cents per share. For the same
quarter last year, the company reported a loss of 4 cents per
share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Streamline
Health Solutions Inc is $2.75, about 34.5% above its last
closing price of $1.80.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Apr. 30 2021 -0.05 -0.05 -0.07 Missed -40
Jan. 31 2021 -0.06 -0.05 Beat 16.7
Oct. 31 2020 -0.07 -0.07 -0.04 Beat 42.9
Jul. 31 2020 -0.04 -0.05 -0.04 Beat 20
Apr. -0.06 -0.06 -0.03 Beat 50
30 2020
Jan. 31 2020 -0.05 -0.05 -0.04 Beat 20
Oct. 31 2019 0.01 0.01 -0.01 Missed -300
Jul. 31 2019 0.01 0.01 -0.02 Missed -300
This summary was machine generated September 6 at 20:14 GMT.
All figures in US dollars unless otherwise stated